1h Free Analyst Time
The premature ejaculation treatment market is poised to grow by $1.26 bn during 2022-2026, accelerating at a CAGR of 9.06% during the forecast period. The report on the premature ejaculation treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the high efficacy of off-label drugs, demand for topical drug therapies for premature ejaculation treatment, and growing risk factors causing premature ejaculation.
The premature ejaculation treatment market analysis includes the route of administration segment and geographic landscape.
The premature ejaculation treatment market is segmented as below:
By Route of Administration
- Oral
- Topical
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the premature ejaculation treatment market covers the following areas:
- Premature ejaculation treatment market sizing
- Premature ejaculation treatment market forecast
- Premature ejaculation treatment market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market through study, synthesis, and summation of data from multiple sources by analyzing key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by Route of Administration
6 Market Segmentation by Drug Class
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Vendor Landscape
11 Vendor Analysis
12 Appendix
List of Exhibits
Executive Summary
The publisher recognizes the following companies as the key players in the global premature ejaculation treatment market: A. Menarini Industrie Farmaceutiche Riunite Srl, Absorption Pharmaceuticals LLC, Alembic Pharmaceuticals Inc., Amneal Pharmaceuticals Inc., ANI Pharmaceuticals Inc., Aytu BioPharma Inc., Bayer AG, Cipla Ltd., Eli Lilly and Co., Endurance RP Ltd., GlaxoSmithKline Plc, Johnson and Johnson, Lupin Ltd., NeuroHealing Pharmaceuticals Inc., Novitium Pharma, Pfizer Inc., Plethora Solutions Ltd., Sandoz International GmbH, Solco Healthcare, and Teva Pharmaceutical Industries Ltd.Commenting on the report, an analyst from the research team said: `The latest trend gaining momentum in the market is the advent of nanotechnology.`
According to the report, one of the major drivers for this market is the high efficacy of off-label drugs.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned
A selection of companies mentioned in this report includes:
- A. Menarini Industrie Farmaceutiche Riunite Srl
- Absorption Pharmaceuticals LLC
- Alembic Pharmaceuticals Inc.
- Amneal Pharmaceuticals Inc.
- ANI Pharmaceuticals Inc.
- Aytu BioPharma Inc.
- Bayer AG
- Cipla Ltd.
- Eli Lilly and Co.
- Endurance RP Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson
- Lupin Ltd.
- NeuroHealing Pharmaceuticals Inc.
- Novitium Pharma
- Pfizer Inc.
- Plethora Solutions Ltd.
- Sandoz International GmbH
- Solco Healthcare
- Teva Pharmaceutical Industries Ltd.